KRRO Stock Analysis: Buy, Sell, or Hold?
KRRO - Korro Bio, Inc. Common Stock
$11.08
0.08 (0.73%)
β²
5d:
-19.48%
30d:
-14.97%
90d:
-0.63%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Get Alerted When KRRO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: KRRO is down 19.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: KRRO is down 19.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: KRRO is currently trading at $11.08, which is considered slightly low relative to its 30-day fair value range of $10.75 to $13.27.
Technical Outlook: Technically, KRRO is in a uptrend. Immediate support is located at $9.12, while resistance sits at $13.99.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.00 (+81.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KRRO is in a uptrend. Immediate support is located at $9.12, while resistance sits at $13.99.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.00 (+81.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$10.75 -
$13.27
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.2%
Protect Your Profits
Holding KRRO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 81.8% below Wall St target ($20.00)
- WARNING: Recommendation downgraded due to -19.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$10.75 -
$13.27
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
Β±$1.18
(10.6%)
Support & Resistance Levels
Support Level
$9.12
Resistance Level
$13.99
Current Trend
Uptrend
Technical data as of
Jun 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.18
Wall Street Target
$20.00
(+81.8%)
Revenue Growth (YoY)
-43.1%
Share & Embed Analysis
Last updated: June 03, 2026 4:40 PM ET
Data refreshes hourly during market hours. Next update: 5:40 PM
Data refreshes hourly during market hours. Next update: 5:40 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KRRO showing a specific setup today?
Insider Activity (6 Months)
9
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Lynx1 Capital Managementβ¦
BUY
520 shares
2026-03-31
Anthony A Jr. Florence
BUY
207100 shares
2026-03-10
Edward T Mathers
BUY
207100 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend BiotechΒ Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
REGN
Regeneron Pharmaceutical⦠|
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I⦠|
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
Advanced KRRO Option Strategies
Professional options setups generated by AI based on today's KRRO price and gamma walls.